Former Illinois Gov. Jim Edgar announced in a statement Monday that he is battling pancreatic cancer. In the statement, Edgar ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Pancreatic cancer often goes undetected until advanced stages Learn about the early warning signs diagnosis methods and ways ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...

Fear of nuclear fallout has led to a novel therapeutic approach that could significantly extend the lives of individuals with ...